<DOC>
	<DOCNO>NCT02211911</DOCNO>
	<brief_summary>To investigate bisacodyl ( Dulcolax® ) sodium picosulfate ( Laxoberal® ) excrete breast milk healthy lactate woman oral administration 10 mg daily period 8 day .</brief_summary>
	<brief_title>Pharmacokinetics Bisacodyl Sodium Picosulfate Administered Orally Healthy Lactating Females</brief_title>
	<detailed_description />
	<mesh_term>Bisacodyl</mesh_term>
	<mesh_term>Picosulfate sodium</mesh_term>
	<criteria>Women , age ≥18 ≤50 year Stopped breast feed baby Provided breast milk sample period 10 day ( include day 1 ) Have breast feeding least 14 day Complied requirement protocol ( e.g complete diary ) Body Mass Index ( BMI ) ≤ 35 kg/m2 Medically acceptable method contraception [ i.e. , double barrier method ( e.g. , diaphragm condom spermicide ) , hormonal therapy ( subcutaneous , injectable , intravaginal , oral contraceptive ) intrauterine device Signed date write informed consent prior study procedure study accordance Good Clinical practice ( GCP ) local legislation Findings medical examination ( include BP , pulse rate ECG ) deviate normal clinical relevance Evidence clinically relevant concomitant disease like renal insufficiency , cardiac insufficiency , myocardial infarction , know cardiovascular disease include hypertension Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder , may interfere safety subject Surgery gastrointestinal tract ( except appendectomy ) last 2 year Metabolic disorder , neurological disorder , severe psychiatric disorder , significant disease intercurrent illness ( e.g . abdominal/gastrointestinal surgery ) would interfere participation study History relevant orthostatic hypotension , faint spell blackouts Chronic relevant acute infection ( e.g . HIV , Hepatitis ) Participated another study investigational product within 1 month prior enrolment study study Eating disorder Hypersensitivity bisacodyl , sodium picosulfate inactive ingredient Any concomitant medication except paracetamol hormonal therapy . Abnormal electrolyte value screen visit . The electrolyte value within normal range Alcohol abuse ; subject report regular consumption 40g/day = 5 units/day alcoholic drink per day exclude Smoker ( &gt; 10 cigarette &gt; 3 cigar &gt; 3 pipes/day ) Drug abuse Any laboratory value outside reference range clinical relevance Mastitis Less 200 ml daily ( 24 hour ) production breast milk day 1 A positive pregnancy test screening</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>